Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | BA7FD | — |
Inappropriate Reconstitution Technique/administered a HIBERIX shot using a different diluent; Inappropriate Reconstitution Technique/administered a HIBERIX shot using a different diluent; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 1-year-old female patient who received Hib (Hiberix) (batch number BA7FD, expiry date 17-MAR-2026) for prophylaxis. On 16-OCT-2025, the patient received Hiberix. On 16-OCT-2025, an unknown time after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Inappropriate Reconstitution Technique/administered a HIBERIX shot using a different diluent) and inappropriate dose of vaccine administered (Verbatim: Inappropriate Reconstitution Technique/administered a HIBERIX shot using a different diluent). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 22-OCT-2025 The nurse called to inform that a female patient was administered a HIBERIX shot using a different diluent than the approved one (sterile water). Patient wanted to know if there were some safety concerns and if revaccination was needed and when to do it. Vaccine was administered on 16 October 2025.